A 200
Latest Information Update: 24 Oct 2021
At a glance
- Originator Amgen
- Class Hormones; Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 17 Dec 2003 No development reported - Clinical-Phase-Unknown for Obesity in USA (SC)
- 14 Mar 2001 New profile
- 14 Mar 2001 Investigation in Obesity in USA (SC)